Abstract:Purpose: To investigate the relationships among docosahexaenoic acid (DHA) intake, nutrient intake, and maternal characteristics on pregnancy outcomes in a phase III randomised clinical trial designed to determine the effect of a DHA dose of 1000 mg/day compared to 200 mg/day on early preterm birth (<34 weeks gestation). Methods: A secondary aim of the phase III randomised trial was to explore the relationships among pregnancy outcomes (maternal red blood cell phospholipid (RBC-PL) DHA at delivery, preterm birth, gestational age at delivery, labor type, birth anthropometric measures, low birth weight, gestational diabetes, pre-eclampsia, and admission to a neonatal intensive care unit) in participants (n = 1100). We used Bayesian multiple imputation and linear and logistic regression models to conduct an analysis of five general classes of predictor variables collected during the trial: a) DHA intake, b) nutrient intake from food and supplements, c) environmental exposure to tobacco and alcohol, d) maternal demographics, and e) maternal medical history. Results: DHA supplementation lowered the risk of preterm birth and NICU admission, and increased gestation and birth weight as observed in the primary analysis. Higher maternal RBC-PL-DHA at delivery was associated with DHA supplementation and formal education of a bachelor's degree or higher. DHA supplementation and maternal age were associated with a higher risk of gestational diabetes. Total vitamin A intake was associated with longer gestation, while fructose and intake of the long chain omega-6 fatty acid, arachidonic acid, were associated with shorter gestation. Risk of preterm birth was associated with a history of low birth weight, preterm birth, pre-eclampsia, and NICU admission. Conclusion: Bayesian models provide a comprehensive approach to relationships among DHA intake, nutrient intake, maternal characteristics, and pregnancy outcomes. We observed previously unreported relationships between gestation duration and fructose, vitamin A, and arachidonic acid that could be the basis for future research. Trial registration number and date: ClinicalTrials.gov (NCT02626299); December 10, 2015.

Self-Reported Intake and Circulating EPA and DHA Concentrations in US Pregnant Women

A Correlation Study Of Dha Intake Estimated By A Ffq And Concentrations In Plasma And Erythrocytes In Mid- And Late Pregnancy

Comparisons of Estimated Intakes and Plasma Concentrations of Selected Fatty Acids in Pregnancy

Self-Reported DHA Supplementation during Pregnancy and Its Association with Obesity or Gestational Diabetes in Relation to DHA Concentration in Cord and Maternal Plasma: Results from NELA, a Prospective Mother-Offspring Cohort

Demographic and health characteristics associated with fish and n-3 fatty acid supplement intake during pregnancy: results from pregnancy cohorts in the ECHO program

Association Between Maternal Erythrocyte PUFAs During Pregnancy and Neurodevelopment in Children at 2 Years of Age: a Birth Cohort Study

The Intake of Omega-3 Fatty Acids, the Omega-3 Index in Pregnant Women, and Their Correlations with Gestational Length and Newborn Birth Weight

Geographic Variations and Determinants of EPA Plus DHA and EPA Alone in Pregnant and Lactating Women from China

Fish Consumption and DHA Supplementation during Pregnancy: Study of Gestational and Neonatal Outcomes

Changes in fatty acid levels (saturated, monounsaturated and polyunsaturated) during pregnancy

Docosahexaenoic Acid Status of Pregnant and Lactating Women in Coastland, Lakeland and Inland of China

Patterns of perinatal polyunsaturated fatty acid status and associated dietary or candidate-genetic factors

Effect of n-3 long-chain polyunsaturated fatty acids supplementation in healthy mothers on DHA and EPA profiles in maternal and umbilical blood: a randomized controlled trial

Plasma concentrations of long chain N-3 fatty acids in early and mid-pregnancy and risk of early preterm birth

Blood fatty acid analysis reveals similar n-3 fatty acid composition in non-pregnant and pregnant women and their neonates in an Israeli pilot study

DHA, nutrient intake, and maternal characteristics as predictors of pregnancy outcomes in a randomised clinical trial of DHA supplementation

Maternal N-3 Fatty Acid Supplementation Has an Immediate Impact on the Human Milk Fatty Acid Composition.

Expanding Awareness of Docosahexaenoic Acid during Pregnancy

Maternal Docosahexaenoic Acid Supplementation Alters Maternal and Fetal Docosahexaenoic Acid Status and Placenta Phospholipids in Pregnancies Complicated by High Body Mass Index

Intrauterine Transfer of Polyunsaturated Fatty Acids in Mother–Infant Dyads as Analyzed at Time of Delivery

Corrigendum to ‘plasma Concentrations of Long Chain N-3 Fatty Acids in Early and Mid-Pregnancy and Risk of Early Preterm Birth’